WK Yih, M Kulldorff, I Dashevsky… - American Journal of …, 2022 - academic.oup.com
The recombinant herpes zoster vaccine (RZV), approved as a 2-dose series in the United
States in October 2017, has proven highly effective and generally safe. However, a small …